|
1
|
Fishback NF, Travis WD, Moran CA, et al:
Pleomorphic (spindle/giant cell) carcinoma of the lung. A
clinicopathologic correlation of 78 cases. Cancer. 73:2936–2945.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bae HM, Min HS, Lee SH, et al: Palliative
chemotherapy for pulmonary pleomorphic carcinoma. Lung Cancer.
58:112–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Park JS, Lee Y, Han J, et al:
Clinicopathologic outcomes of curative resection for sarcomatoid
carcinoma of the Lung. Oncology. 81:206–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yendamuri S, Caty L, Pine M, et al:
Outcomes of sarcomatoid carcinoma of the lung: A Surveillance,
Epidemiology and End Results Database analysis. Surgery.
152:397–402. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rossi G, Cavazza A, Sturm N, et al:
Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous
elements: A clinicopathologic and immunohistochemical study of 75
cases. Am J Surg Pathol. 27:311–324. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yuki T, Sakuma T, Ohbayashi C, et al:
Pleomorphic carcinoma of the lung: A surgical outcome. J Thorac
Cardiovasc Surg. 134:399–404. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mochizuki T, Ishii G, Nagai K, et al:
Pleomorphic carcinoma of the lung: Clinicopathologic
characteristics of 70 cases. Am J Surg Pathol. 32:1727–1735. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ito K, Oizumi S, Fukumoto S, et al:
Clinical characteristics of pleomorphic carcinoma of the lung. Lung
Cancer. 68:204–210. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hong JY, Choi MK, Uhm JE, et al: The role
of palliative chemotherapy for advanced pulmonary pleomorphic
carcinoma. Med Oncol. 26:287–291. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oken MM, Creech RH, Tormey DC, et al:
Toxicity and response criteria of the Eastern Cooperative Oncology
Group. Am J Clin Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goldstraw P, Crowley J, Chansky K, et al:
Proposals for the revision of the TNM stage groupings in the
forthcoming (seventh) edition of the TNM Classification of
malignant tumours. J Thorac Oncol. 2:706–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Travis WD, Colby TV, Corrin B, et al:
Histological Typing of Lung Tumors and Pleural Tumors (Third).
Springer Verlag. Berlin: 1999. View Article : Google Scholar
|
|
13
|
Brambilla E, Travis WD, Colby TV, Corrin B
and Shimosato Y: The new World Health Organization classification
of lung tumors. Eur Respir J. 18:1059–1068. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shannon RL, Ro JY, Grignon DJ, et al:
Sarcomatoid carcinoma of the prostate. A clinicopathologic study of
12 patients. Cancer. 69:2676–2682. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee KW, Kim YJ, Kim JH, et al: Two
consecutive cases of platinum-refractory pulmonary pleomorphic
carcinoma that showed dramatic responses to MAID (mesna,
doxorubicin, ifosfamide and dacarbazine) chemotherapy. Jpn J Clin
Oncol. 41:430–433. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kawano R, Hino H, Hoshino T, et al:
Clinicopathological investi- gation of seven resected cases of
pleomorphic carcinoma of the lung and the results of their
chemosensitivity tests. Haigan (Jpn J Lung Cancer). 48:106–111.
2008.(In Japanese). View Article : Google Scholar
|
